Lido Advisors LLC increased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 90.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 25,613 shares of the company’s stock after acquiring an additional 12,157 shares during the quarter. Lido Advisors LLC’s holdings in GE HealthCare Technologies were worth $1,674,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of GEHC. State Street Corp raised its position in GE HealthCare Technologies by 1.6% in the 2nd quarter. State Street Corp now owns 20,861,566 shares of the company’s stock valued at $1,335,349,000 after purchasing an additional 323,090 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC grew its position in GE HealthCare Technologies by 13.2% during the 2nd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 13,455,814 shares of the company’s stock worth $861,307,000 after purchasing an additional 1,571,226 shares during the last quarter. Dimensional Fund Advisors LP grew its position in GE HealthCare Technologies by 2.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 5,399,439 shares of the company’s stock worth $384,219,000 after purchasing an additional 105,995 shares during the last quarter. Van ECK Associates Corp grew its position in GE HealthCare Technologies by 4.1% during the 2nd quarter. Van ECK Associates Corp now owns 4,482,631 shares of the company’s stock worth $286,933,000 after purchasing an additional 177,028 shares during the last quarter. Finally, Trian Fund Management L.P. grew its position in GE HealthCare Technologies by 76,194.4% during the 2nd quarter. Trian Fund Management L.P. now owns 3,085,344 shares of the company’s stock worth $197,493,000 after purchasing an additional 3,081,300 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.
GE HealthCare Technologies Price Performance
Shares of NASDAQ GEHC opened at $83.02 on Monday. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.30 and a quick ratio of 1.01. The stock has a fifty day moving average price of $70.55 and a 200 day moving average price of $70.11. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The company has a market cap of $37.54 billion, a PE ratio of 17.51, a P/E/G ratio of 2.09 and a beta of 0.64.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its quarterly earnings data on Wednesday, October 28th. The company reported $1.34 earnings per share for the quarter, beating analysts’ consensus estimates of $1.20 by $0.14. The firm had revenue of $5.51 billion for the quarter, compared to analyst estimates of $5.35 billion. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. GE HealthCare Technologies’s quarterly revenue was up 7.2% on a year-over-year basis. During the same period last year, the firm posted $1.07 EPS. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 5.02 EPS for the current year.
GE HealthCare Technologies Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, November 13th. Stockholders of record on Friday, October 23rd were paid a $0.04 dividend. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. The ex-dividend date was Friday, October 23rd. This represents a $0.16 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.38%.
Wall Street Analysts Forecast Growth
GEHC has been the topic of a number of recent research reports. Wolfe Research began coverage on shares of GE HealthCare Technologies in a research note on Tuesday, October 20th. They issued a “peer perform” rating on the stock. Wells Fargo & Company increased their target price on shares of GE HealthCare Technologies from $75.00 to $85.00 and gave the stock an “overweight” rating in a research note on Thursday, July 30th. Royal Bank Of Canada raised their price target on GE HealthCare Technologies from $80.00 to $90.00 and gave the stock an “outperform” rating in a report on Thursday, October 29th. Needham & Company LLC reissued a “buy” rating and set a $93.00 price target on shares of GE HealthCare Technologies in a report on Monday, October 5th. Finally, BTIG Research boosted their price target on GE HealthCare Technologies from $75.00 to $83.00 and gave the company a “buy” rating in a research report on Wednesday, October 28th. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $82.17.
View Our Latest Stock Analysis on GEHC
About GE HealthCare Technologies
GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.
Read More
- Five stocks we like better than GE HealthCare Technologies
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
